Genetic study of diabetic retinopathy: Recruitment methodology and analysis of baseline characteristics

Georgia Kaidonis, Sotoodeh Abhary, Mark Daniell, Mark Gillies, Rhys Fogarty, Nikolai Petrovsky, Alicia Jenkins, Rohan Essex, John H. Chang, Bishwanath Pal, Alex W. Hewitt, Kathryn P. Burdon, Jamie E. Craig

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Diabetic retinopathy (DR) is a blinding disease of increasing prevalence that is caused by a complex interplay of genetic and environmental factors. Here we describe the patient recruitment methodology, case and control definitions, and clinical characteristics of a study sample to be used for genome-wide association analysis to detect genetic risk variants of DR. Methods: One thousand six hundred sixty-nine participants with either type 1 (T1) or type 2 (T2) diabetes mellitus (DM) aged 18 to 95 years were recruited in Australian hospital clinics. Individuals with T2DM had disease duration of at least 5 years and were taking oral hypoglycaemic medication, and/or insulin therapy. Participants underwent ophthalmic examination. Medical history and biochemistry results were collected. Venous blood was obtained for genetic analysis. Results: Six hundred eighty-three diabetic cases (178 T1DM and 505 T2DM participants) with sight-threatening DR, defined as severe non-proliferative DR, proliferative DR or diabetic macular oedema were included in this analysis. Eight hundred twelve individuals with DM but no DR or minimal non-proliferative DR were recruited as controls (191 with T1DM and 621 with T2DM). The presence of sight-threatening DR was significantly correlated with DM duration, hypertension, nephropathy, neuropathy, HbA1C and body mass index. Diabetic macular oedema was associated with T2DM (P<0.001), whereas proliferative DR was associated with T1DM (P<0.001). Conclusions: Adoption of a case-control study design involving extremes of the DR phenotype makes this a suitable cohort, for a well-powered genome-wide association study to detect genetic risk variants for DR.

LanguageEnglish
Pages486-493
Number of pages8
JournalClinical and Experimental Ophthalmology
Volume42
Issue number5
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • Diabetic macular oedema
  • Diabetic retinopathy
  • Genome-wide association study

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Kaidonis, Georgia ; Abhary, Sotoodeh ; Daniell, Mark ; Gillies, Mark ; Fogarty, Rhys ; Petrovsky, Nikolai ; Jenkins, Alicia ; Essex, Rohan ; Chang, John H. ; Pal, Bishwanath ; Hewitt, Alex W. ; Burdon, Kathryn P. ; Craig, Jamie E. / Genetic study of diabetic retinopathy : Recruitment methodology and analysis of baseline characteristics. In: Clinical and Experimental Ophthalmology. 2014 ; Vol. 42, No. 5. pp. 486-493.
@article{609048a63f644691b39e132926bf0afb,
title = "Genetic study of diabetic retinopathy: Recruitment methodology and analysis of baseline characteristics",
abstract = "Background: Diabetic retinopathy (DR) is a blinding disease of increasing prevalence that is caused by a complex interplay of genetic and environmental factors. Here we describe the patient recruitment methodology, case and control definitions, and clinical characteristics of a study sample to be used for genome-wide association analysis to detect genetic risk variants of DR. Methods: One thousand six hundred sixty-nine participants with either type 1 (T1) or type 2 (T2) diabetes mellitus (DM) aged 18 to 95 years were recruited in Australian hospital clinics. Individuals with T2DM had disease duration of at least 5 years and were taking oral hypoglycaemic medication, and/or insulin therapy. Participants underwent ophthalmic examination. Medical history and biochemistry results were collected. Venous blood was obtained for genetic analysis. Results: Six hundred eighty-three diabetic cases (178 T1DM and 505 T2DM participants) with sight-threatening DR, defined as severe non-proliferative DR, proliferative DR or diabetic macular oedema were included in this analysis. Eight hundred twelve individuals with DM but no DR or minimal non-proliferative DR were recruited as controls (191 with T1DM and 621 with T2DM). The presence of sight-threatening DR was significantly correlated with DM duration, hypertension, nephropathy, neuropathy, HbA1C and body mass index. Diabetic macular oedema was associated with T2DM (P<0.001), whereas proliferative DR was associated with T1DM (P<0.001). Conclusions: Adoption of a case-control study design involving extremes of the DR phenotype makes this a suitable cohort, for a well-powered genome-wide association study to detect genetic risk variants for DR.",
keywords = "Diabetic macular oedema, Diabetic retinopathy, Genome-wide association study",
author = "Georgia Kaidonis and Sotoodeh Abhary and Mark Daniell and Mark Gillies and Rhys Fogarty and Nikolai Petrovsky and Alicia Jenkins and Rohan Essex and Chang, {John H.} and Bishwanath Pal and Hewitt, {Alex W.} and Burdon, {Kathryn P.} and Craig, {Jamie E.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/ceo.12239",
language = "English",
volume = "42",
pages = "486--493",
journal = "Clinical and Experimental Ophthalmology",
issn = "1442-6404",
publisher = "Wiley-Blackwell",
number = "5",

}

Kaidonis, G, Abhary, S, Daniell, M, Gillies, M, Fogarty, R, Petrovsky, N, Jenkins, A, Essex, R, Chang, JH, Pal, B, Hewitt, AW, Burdon, KP & Craig, JE 2014, 'Genetic study of diabetic retinopathy: Recruitment methodology and analysis of baseline characteristics', Clinical and Experimental Ophthalmology, vol. 42, no. 5, pp. 486-493. https://doi.org/10.1111/ceo.12239

Genetic study of diabetic retinopathy : Recruitment methodology and analysis of baseline characteristics. / Kaidonis, Georgia; Abhary, Sotoodeh; Daniell, Mark; Gillies, Mark; Fogarty, Rhys; Petrovsky, Nikolai; Jenkins, Alicia; Essex, Rohan; Chang, John H.; Pal, Bishwanath; Hewitt, Alex W.; Burdon, Kathryn P.; Craig, Jamie E.

In: Clinical and Experimental Ophthalmology, Vol. 42, No. 5, 01.01.2014, p. 486-493.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genetic study of diabetic retinopathy

T2 - Clinical and Experimental Ophthalmology

AU - Kaidonis, Georgia

AU - Abhary, Sotoodeh

AU - Daniell, Mark

AU - Gillies, Mark

AU - Fogarty, Rhys

AU - Petrovsky, Nikolai

AU - Jenkins, Alicia

AU - Essex, Rohan

AU - Chang, John H.

AU - Pal, Bishwanath

AU - Hewitt, Alex W.

AU - Burdon, Kathryn P.

AU - Craig, Jamie E.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: Diabetic retinopathy (DR) is a blinding disease of increasing prevalence that is caused by a complex interplay of genetic and environmental factors. Here we describe the patient recruitment methodology, case and control definitions, and clinical characteristics of a study sample to be used for genome-wide association analysis to detect genetic risk variants of DR. Methods: One thousand six hundred sixty-nine participants with either type 1 (T1) or type 2 (T2) diabetes mellitus (DM) aged 18 to 95 years were recruited in Australian hospital clinics. Individuals with T2DM had disease duration of at least 5 years and were taking oral hypoglycaemic medication, and/or insulin therapy. Participants underwent ophthalmic examination. Medical history and biochemistry results were collected. Venous blood was obtained for genetic analysis. Results: Six hundred eighty-three diabetic cases (178 T1DM and 505 T2DM participants) with sight-threatening DR, defined as severe non-proliferative DR, proliferative DR or diabetic macular oedema were included in this analysis. Eight hundred twelve individuals with DM but no DR or minimal non-proliferative DR were recruited as controls (191 with T1DM and 621 with T2DM). The presence of sight-threatening DR was significantly correlated with DM duration, hypertension, nephropathy, neuropathy, HbA1C and body mass index. Diabetic macular oedema was associated with T2DM (P<0.001), whereas proliferative DR was associated with T1DM (P<0.001). Conclusions: Adoption of a case-control study design involving extremes of the DR phenotype makes this a suitable cohort, for a well-powered genome-wide association study to detect genetic risk variants for DR.

AB - Background: Diabetic retinopathy (DR) is a blinding disease of increasing prevalence that is caused by a complex interplay of genetic and environmental factors. Here we describe the patient recruitment methodology, case and control definitions, and clinical characteristics of a study sample to be used for genome-wide association analysis to detect genetic risk variants of DR. Methods: One thousand six hundred sixty-nine participants with either type 1 (T1) or type 2 (T2) diabetes mellitus (DM) aged 18 to 95 years were recruited in Australian hospital clinics. Individuals with T2DM had disease duration of at least 5 years and were taking oral hypoglycaemic medication, and/or insulin therapy. Participants underwent ophthalmic examination. Medical history and biochemistry results were collected. Venous blood was obtained for genetic analysis. Results: Six hundred eighty-three diabetic cases (178 T1DM and 505 T2DM participants) with sight-threatening DR, defined as severe non-proliferative DR, proliferative DR or diabetic macular oedema were included in this analysis. Eight hundred twelve individuals with DM but no DR or minimal non-proliferative DR were recruited as controls (191 with T1DM and 621 with T2DM). The presence of sight-threatening DR was significantly correlated with DM duration, hypertension, nephropathy, neuropathy, HbA1C and body mass index. Diabetic macular oedema was associated with T2DM (P<0.001), whereas proliferative DR was associated with T1DM (P<0.001). Conclusions: Adoption of a case-control study design involving extremes of the DR phenotype makes this a suitable cohort, for a well-powered genome-wide association study to detect genetic risk variants for DR.

KW - Diabetic macular oedema

KW - Diabetic retinopathy

KW - Genome-wide association study

UR - http://www.scopus.com/inward/record.url?scp=84904740462&partnerID=8YFLogxK

U2 - 10.1111/ceo.12239

DO - 10.1111/ceo.12239

M3 - Article

VL - 42

SP - 486

EP - 493

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

SN - 1442-6404

IS - 5

ER -